428 related articles for article (PubMed ID: 33615463)
21. Phage therapy for severe bacterial infections: a narrative review.
Petrovic Fabijan A; Khalid A; Maddocks S; Ho J; Gilbey T; Sandaradura I; Lin RC; Ben Zakour N; Venturini C; Bowring B; Iredell JR
Med J Aust; 2020 Apr; 212(6):279-285. PubMed ID: 31587298
[TBL] [Abstract][Full Text] [Related]
22. Biological challenges of phage therapy and proposed solutions: a literature review.
Caflisch KM; Suh GA; Patel R
Expert Rev Anti Infect Ther; 2019 Dec; 17(12):1011-1041. PubMed ID: 31735090
[No Abstract] [Full Text] [Related]
23. Evolutionary Rationale for Phages as Complements of Antibiotics.
Torres-Barceló C; Hochberg ME
Trends Microbiol; 2016 Apr; 24(4):249-256. PubMed ID: 26786863
[TBL] [Abstract][Full Text] [Related]
24. Beyond Antibiotics: New Therapeutic Approaches for Bacterial Infections.
Hauser AR; Mecsas J; Moir DT
Clin Infect Dis; 2016 Jul; 63(1):89-95. PubMed ID: 27025826
[TBL] [Abstract][Full Text] [Related]
25. Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.
Dąbrowska K; Abedon ST
Microbiol Mol Biol Rev; 2019 Nov; 83(4):. PubMed ID: 31666296
[TBL] [Abstract][Full Text] [Related]
26. The potential of phage therapy in cystic fibrosis: Essential human-bacterial-phage interactions and delivery considerations for use in Pseudomonas aeruginosa-infected airways.
Trend S; Fonceca AM; Ditcham WG; Kicic A; Cf A
J Cyst Fibros; 2017 Nov; 16(6):663-670. PubMed ID: 28720345
[TBL] [Abstract][Full Text] [Related]
27. Bacteriophages for ESKAPE: role in pathogenicity and measures of control.
Patil A; Banerji R; Kanojiya P; Koratkar S; Saroj S
Expert Rev Anti Infect Ther; 2021 Jul; 19(7):845-865. PubMed ID: 33261536
[TBL] [Abstract][Full Text] [Related]
28. Bacteriophage-mediated modulation of microbiota for diseases treatment.
Zhang Y; Li CX; Zhang XZ
Adv Drug Deliv Rev; 2021 Sep; 176():113856. PubMed ID: 34237403
[TBL] [Abstract][Full Text] [Related]
29. Stronger together? Perspectives on phage-antibiotic synergy in clinical applications of phage therapy.
Segall AM; Roach DR; Strathdee SA
Curr Opin Microbiol; 2019 Oct; 51():46-50. PubMed ID: 31226502
[TBL] [Abstract][Full Text] [Related]
30. Bacteriophages: A Therapy Concept against Multi-Drug-Resistant Bacteria.
Rohde C; Wittmann J; Kutter E
Surg Infect (Larchmt); 2018; 19(8):737-744. PubMed ID: 30256176
[TBL] [Abstract][Full Text] [Related]
31. Ameliorating the antimicrobial resistance crisis: phage therapy.
Saha D; Mukherjee R
IUBMB Life; 2019 Jul; 71(7):781-790. PubMed ID: 30674079
[TBL] [Abstract][Full Text] [Related]
32. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy.
Tagliaferri TL; Jansen M; Horz HP
Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237
[TBL] [Abstract][Full Text] [Related]
33. Phage Therapy in the Twenty-First Century: Facing the Decline of the Antibiotic Era; Is It Finally Time for the Age of the Phage?
Hesse S; Adhya S
Annu Rev Microbiol; 2019 Sep; 73():155-174. PubMed ID: 31185183
[TBL] [Abstract][Full Text] [Related]
34. Bacteriophage Therapeutics: A Primer for Clinicians on Phage-Antibiotic Combinations.
Morrisette T; Kebriaei R; Lev KL; Morales S; Rybak MJ
Pharmacotherapy; 2020 Feb; 40(2):153-168. PubMed ID: 31872889
[TBL] [Abstract][Full Text] [Related]
35. Applications of bacteriophages versus phage enzymes to combat and cure bacterial infections: an ambitious and also a realistic application?
Maciejewska B; Olszak T; Drulis-Kawa Z
Appl Microbiol Biotechnol; 2018 Mar; 102(6):2563-2581. PubMed ID: 29442169
[TBL] [Abstract][Full Text] [Related]
36. [Bacteriophages in the battle against multidrug resistant bacteria].
van der Meer JWM; Vandenbroucke-Grauls CMJE
Ned Tijdschr Geneeskd; 2018; 162():D2433. PubMed ID: 29600928
[TBL] [Abstract][Full Text] [Related]
37. Bacteriophages and phage-delivered CRISPR-Cas system as antibacterial therapy.
Yeh TK; Jean SS; Lee YL; Lu MC; Ko WC; Lin HJ; Liu PY; Hsueh PR
Int J Antimicrob Agents; 2022 Jan; 59(1):106475. PubMed ID: 34767917
[TBL] [Abstract][Full Text] [Related]
38. [Phage therapy for bacterial infection of burn].
Peng YZ; Huang GT
Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):513-6. PubMed ID: 27647065
[TBL] [Abstract][Full Text] [Related]
39. Naturally-occurring and cultured bacteriophages in human therapy.
Kiani AK; Anpilogov K; Dhuli K; Paolacci S; Benedetti S; Manara E; Guerri G; Dautaj A; Beccari T; Dundar M; Bertelli M
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(1 Suppl):101-107. PubMed ID: 34890040
[TBL] [Abstract][Full Text] [Related]
40. Phage Therapy: The Pharmacology of Antibacterial Viruses.
Danis-Wlodarczyk K; Dąbrowska K; Abedon ST
Curr Issues Mol Biol; 2021; 40():81-164. PubMed ID: 32503951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
